Tectonic Therapeutic | AVRO - Cash And Equivalent


Tectonic Therapeutic reported $268.44M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Alnylam Pharmaceuticals USD 1.49B 376.56M Sep/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
MacroGenics USD 80.13M 50.56M Sep/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sarepta Therapeutics USD 613.08M 102.48M Sep/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Takeda JPY 654.94B 26.55B Dec/2025
Tilray USD 264.83M 43.16M Jun/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025